Well done @RaceOncolgy, good presentation, I thought that you were successful in using simple language without talking down to the audience, something which I am not convinced that all presenters achieved.
If I can make a suggestion it would be to work on how you explpain the reason for bisantrene being dropped by Lederle. It was mentioned, but I think it helps to really underline the difference between delivery through a central line and delivery via IV and the fact that you were able to solve that problem with RC220 (employing new technology that wasn't available to Lederle if I'm not mistaken). I think it's hard for new investors to believe why a drug that is supposed to be so successful decades ago was dropped.
Well done @RaceOncolgy, good presentation, I thought that you...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.59 |
Change
-0.020(1.25%) |
Mkt cap ! $272.6M | |||
| Open | High | Low | Value | Volume |
| $1.62 | $1.62 | $1.58 | $68.76K | 43.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 193 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 757 | 1 |
View Market Depth
| Last trade - 12.07pm 09/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |